All Posts: News Release
-
“SNIFF,” a Nasal Insulin Study for Alzheimer’s, Now Underway at Georgetown
WASHINGTON – Georgetown University’s Memory Disorders Program is looking for volunteers to participate in a study to see if insulin, the hormone used to treat diabetes, can improve cognition, memory and daily function in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease.
Category: News Release
-
Georgetown Study Opens for Those With Inherited Genetic Risk for Alzheimer’s Disease
WASHINGTON — The Memory Disorders Program at Georgetown University Medical Center is seeking volunteers to participate in a study testing two agents to slow the onset and progression of Alzheimer’s disease. Cognitively normal individuals with a particular genetic risk of developing the disorder are being sought.
Category: News Release
-
Georgetown, Children’s National Researchers To Evaluate Sesame Workshop’s Autism Initiative
WASHINGTON — Sesame Workshop, the nonprofit educational organization behind Sesame Street, has selected Georgetown University Medical Center and Children’s National Health System researchers to lead an evaluation of “Sesame Street and Autism: See Amazing in All Children,” an initiative developed to reduce stigma and build understanding about autism spectrum disorder (ASD).
Category: News Release
-
First Diagnosed Case of Alzheimer’s Disease in HIV-Positive Individual Reported
WASHINGTON (April 15, 2016) — Georgetown University researchers are reporting the first case of Alzheimer’s disease diagnosed in an HIV-positive individual. The finding in a 71-year-old man triggers a realization about HIV survivors now reaching the age when Alzheimer’s risk begins to escalate. Published online in the open access journal Alzheimer’s & Dementia: Diagnosis, Assessment & Disease […]
Category: News Release
-
West Africa, Ebola and the Threat of Zika
WASHINGTON — Rapid testing for the Zika virus is a critical need in the recent Ebola-affected countries of Liberia, Sierra Leone and Guinea, says a Georgetown University professor, because of the recent Zika outbreak on nearby Cape Verde and the similarity in symptoms between Zika and early Ebola.
Category: News Release
-
10-Minute Urine Test Can Measure Specific Compounds from Food Consumed
Researchers at Georgetown Lombardi Comprehensive Cancer Center in Washington, DC, have developed a method that can quickly evaluate specific food compounds in human urine. They say their method could one day replace unreliable food logs used in population studies examining the effects of diet on cancer and will also help scientists accurately identify the most beneficial anticancer foods.
Category: News Release
-
Georgetown Scholar Available to Discuss WHO Report on Health and Environmental Impacts
WASHINGTON — Anticipating the World Health Organization’s report on health and environmental impacts (expected March 15), Georgetown professor Laura Anderko, PhD, RN, points out that environmental harms unfairly impact the most vulnerable people in the world.
Category: News Release
-
Georgetown Author Says Radiation Fears Will Be “Rearranged” With New Book, Strange Glow
WASHINGTON — It’s a common paradox. Why is it that some people fear using cellphones believing radiation from the device will cause a brain tumor, but will gladly have a whole body CT scan to check for diseases without any signs or symptoms of anything wrong? Why do others fear microwave ovens, but have no issue with the nearby nuclear power plant that provides electricity for their kitchens?
The answer is that most people do not understand radiation in a way that allows them to make an accurate assessment of its health risks, says a Georgetown’s Timothy J. Jorgensen.
Category: News Release
-
Congressional Testimony on "Bioethics and Fetal Tissue" by G. Kevin Donovan, MD
Written Testimony of G. Kevin Donovan, MD, director of the Pellegrino Center for Clinical Bioethics at Georgetown University Medical Center, a witness before the Select Investigative Panel of the Committee on Energy and Commerce on March 2, 2016 for a hearing on “Bioethics and Fetal Tissue.”
Category: News Release
-
Georgetown Seeks Volunteers for New Immunotherapy Clinical Trial for Alzheimer’s
WASHINGTON — The Memory Disorders Program at Georgetown University is seeking volunteers to participate in an international clinical trial of a drug that, in an early phase study, has demonstrated promise in slowing mental decline in Alzheimer’s disease. Georgetown is the only institution in the greater Washington, DC, area offering access to the phase 3 study of the investigational immunotherapy drug aducanumab.
Category: News Release